Michel De Ceuninck

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction

Marc J. Claeys, Johan Bosmans, Michel De Ceuninck et al. · The American Journal of Cardiology · 2004 · 85 citations

Percutaneous Coronary Intervention, Intracoronary Adenosine Infusion, Cardiogenic Shock +8

Acetazolamide in Decompensated Heart Failure with Volume Overload trial ( <scp>ADVOR</scp> ): baseline characteristics

Wilfried Müllens, Jeroen Dauw, Pieter Martens et al. · European Journal of Heart Failure · 2022 · 37 citations · Full text

Left Ventricular End-Systolic Dimension and Outcome in Patients With Heart Failure Undergoing Percutaneous MitraClip Valve Repair for Secondary Mitral Regurgitation

Philippe Debonnaire, Caroline M. Van De Heyning, Milad El Haddad et al. · The American Journal of Cardiology · 2020 · 16 citations

Heart Failure, Secondary Mitral Regurgitation, Valve Disease +5

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 14 citations · Full text